132 related articles for article (PubMed ID: 15734058)
1. Challenges in creating a vaccine to prevent hepatitis E.
Maloney BJ; Takeda N; Suzaki Y; Ami Y; Li TC; Miyamura T; Arntzen CJ; Mason HS
Vaccine; 2005 Mar; 23(15):1870-4. PubMed ID: 15734058
[TBL] [Abstract][Full Text] [Related]
2. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA
Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540
[TBL] [Abstract][Full Text] [Related]
4. [Expression, purification and immunogenicity of a novel hepatitis E virus-like particle].
Dong C; Meng JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):339-42. PubMed ID: 16643795
[TBL] [Abstract][Full Text] [Related]
5. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates.
Li SW; Zhang J; Li YM; Ou SH; Huang GY; He ZQ; Ge SX; Xian YL; Pang SQ; Ng MH; Xia NS
Vaccine; 2005 Apr; 23(22):2893-901. PubMed ID: 15780738
[TBL] [Abstract][Full Text] [Related]
6. A preliminary study on immune response to hepatitis E virus DNA vaccine in mice.
Lu F; Zhuang H; Zhu Y; Zhu X
Chin Med J (Engl); 1996 Dec; 109(12):919-21. PubMed ID: 9275321
[TBL] [Abstract][Full Text] [Related]
7. The sweet potato ADP-glucose pyrophosphorylase gene (ibAGP1) promoter confers high-level expression of the GUS reporter gene in the potato tuber.
Kim TW; Goo YM; Lee CH; Lee BH; Bae JM; Lee SW
C R Biol; 2009 Oct; 332(10):876-85. PubMed ID: 19819408
[TBL] [Abstract][Full Text] [Related]
8. Oral immunogenicity of potato-derived HBsAg middle protein in BALB/c mice.
Youm JW; Won YS; Jeon JH; Ryu CJ; Choi YK; Kim HC; Kim BD; Joung H; Kim HS
Vaccine; 2007 Jan; 25(3):577-84. PubMed ID: 16945456
[TBL] [Abstract][Full Text] [Related]
9. Development of candidate combination vaccine for hepatitis E and hepatitis B: a liposome encapsulation approach.
Shrivastava S; Lole KS; Tripathy AS; Shaligram US; Arankalle VA
Vaccine; 2009 Nov; 27(47):6582-8. PubMed ID: 19747579
[TBL] [Abstract][Full Text] [Related]
10. Production of hepatitis B surface antigen in transgenic plants for oral immunization.
Richter LJ; Thanavala Y; Arntzen CJ; Mason HS
Nat Biotechnol; 2000 Nov; 18(11):1167-71. PubMed ID: 11062435
[TBL] [Abstract][Full Text] [Related]
11. Protection of chickens against avian hepatitis E virus (avian HEV) infection by immunization with recombinant avian HEV capsid protein.
Guo H; Zhou EM; Sun ZF; Meng XJ
Vaccine; 2007 Apr; 25(15):2892-9. PubMed ID: 17074425
[TBL] [Abstract][Full Text] [Related]
12. [Immunogenicity of experimentally combined hepatitis A and hepatitis E vaccine at different dosage ratio].
Dong C; Dai X; Meng JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):130-3. PubMed ID: 17286906
[TBL] [Abstract][Full Text] [Related]
13. A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus.
Zhou YH; Purcell RH; Emerson SU
Vaccine; 2005 May; 23(24):3157-65. PubMed ID: 15837215
[TBL] [Abstract][Full Text] [Related]
14. Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes.
Arankalle VA; Lole KS; Deshmukh TM; Srivastava S; Shaligram US
Vaccine; 2009 Feb; 27(7):1032-9. PubMed ID: 19095027
[TBL] [Abstract][Full Text] [Related]
15. Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes.
Tacket CO; Mason HS; Losonsky G; Estes MK; Levine MM; Arntzen CJ
J Infect Dis; 2000 Jul; 182(1):302-5. PubMed ID: 10882612
[TBL] [Abstract][Full Text] [Related]
16. Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses.
Huang Z; Elkin G; Maloney BJ; Beuhner N; Arntzen CJ; Thanavala Y; Mason HS
Vaccine; 2005 Mar; 23(15):1851-8. PubMed ID: 15734055
[TBL] [Abstract][Full Text] [Related]
17. Feeding of mice with Arabidopsis thaliana expressing the HIV-1 subtype C p24 antigen gives rise to systemic immune responses.
Lindh I; Kalbina I; Thulin S; Scherbak N; Sävenstrand H; Bråve A; Hinkula J; Strid A; Andersson S
APMIS; 2008 Nov; 116(11):985-94. PubMed ID: 19132995
[TBL] [Abstract][Full Text] [Related]
18. The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E.
Dong C; Dai X; Meng JH
Vaccine; 2007 Feb; 25(9):1662-8. PubMed ID: 17156900
[TBL] [Abstract][Full Text] [Related]
19. Lessons from hepatitis E vaccine design.
Li S; Zhang J; Xia N
Curr Opin Virol; 2015 Apr; 11():130-6. PubMed ID: 25913817
[TBL] [Abstract][Full Text] [Related]
20. Modeling the long-term antibody response of a hepatitis E vaccine.
Chen S; Zhou Z; Wei FX; Huang SJ; Tan Z; Fang Y; Zhu FC; Wu T; Zhang J; Xia NS
Vaccine; 2015 Aug; 33(33):4124-9. PubMed ID: 26126668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
